Venous gangrene of lower extremities and Staphylococcus aureus sepsis

Journal of Perinatology : Official Journal of the California Perinatal Association
H IbrahimR Dhanireddy

Abstract

This is a study of the venous gangrene of lower extremities and Staphylococcus aureus sepsis. We report on a premature infant who developed phlegmasia cerulea dolens (PCD) in both lower extremities in association with S. aureus sepsis, resulting in gangrene of the right foot. Non-pitting edema and cyanosis of the digits of the right lower extremity were noted 48 hours after hypotension and severe shock due to S. aureus sepsis. Intravenous antibiotics, isotonic fluids, and heparin were administered. Twenty-four hours later, edema and ischemic changes of the first and fifth left toes were also noted. Doppler flow study showed flow signals in both right and left popliteal arteries. However, there were no Doppler signals in neither right nor left popliteal vein. Emergency fasciotomies were performed on both lower limbs. The progression of the gangrene was limited to the right foot. There was complete resolution of PCD in both lower extremities. To the best of our knowledge, the association of S. aureus sepsis with PCD and venous gangrene in an infant has not been reported previously. This case illustrates the need for early recognition of PCD and aggressive intervention.

References

Jun 1, 1979·The British Journal of Surgery·M S ElliotJ H Louw
Nov 1, 1975·Clinical Orthopaedics and Related Research·T E WhitesidesH Harada
Mar 1, 1988·Southern Medical Journal·F A WeaverR H Dean
Jul 1, 1987·Archives of Dermatology·J V Hirschmann
Jun 1, 1997·The Journal of Hand Surgery : Journal of the British Society for Surgery of the Hand·A R FittonM Smithies
Apr 29, 1998·American Journal of Surgery·M SchurrR Helgerson
Aug 26, 1998·The New England Journal of Medicine·F D Lowy

❮ Previous
Next ❯

Citations

Oct 21, 2009·Pediatric Dermatology·Sriram KrishnamurthyPiyush Gupta
Jan 5, 2011·Vascular and Endovascular Surgery·Khamin ChinsakchaiGert J de Borst

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2021 Meta ULC. All rights reserved